SMi are proud to present their 4th annual KOL Management & MSL Best Practice in Europe conference taking place on 2nd & 3rd July 2012, in Basel, Switzerland. The 2012 event will bring together senior Pharma executives and key opinion leaders to discuss current issues in the field. With presentations from industry representatives from all over the pharmaceutical sector, this event promises to be a unique platform for networking and problem solving in the major challenges facing KOL Development. The event will focus on MSL best practice strategies in a variety of contexts and amongst other subjects will consider how best to utilize digital media in KOL management. New Speaker - Kristian Loebner, Director, Medical Affairs, AstraZeneca GmbH Key Benefits of Attending: Hear from leading industry experts from major pharmaceutical companies about compliance challenges in KOL interaction Consider effective MSL development strategies in orphan disease markets Understand the importance of KOL management in developing countries Discuss with patient advocacy groups how best to build and sustain effective Explore MSL best practice strategies in promotional and marketing activities Learn how best to utilize digital media in KOL management Visit our website here: http://www.
Meet Industry Experts And Discuss The Latest Advances In Drug Development At SMi's Pain Therapeutics 21-22 May 2012, London
Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK. Pain is the most common reason patients seek medical care, as it affects the quality of life many people experience and has significant sensory and emotional components. Whilst advances have been made in pain management, few significant ones have occurred, making it harder in recent years to get analgesics to market. In the current economic climate, this makes it even more imperative for companies to improve their R&D methods so that drugs being put forward for clinical trials have the best chance of success. Hear key presentations from industry-leading experts: Kevin Lee, Head of Epigenetics Discovery Unit, Epinova (GlaxoSmithKline) Chas Bountra, Professor of Translational Medicine, Head, Structural Genomics Centre Oxford University Jonathan Stewart, Disease Area Head, Neuroscience, Immunology and Pain, Bristol-Myers Squibb Philip Kym, Associate Director II Pain Discovery Research, Abbott Mark Bowlby, Neurophysiology and Pain Lead, Merck Dave Shelton, Senior Director, Pfizer Global Research & Development Key reasons to attend: Evaluate recent advances in experimental pain models and translational techniques Discuss the current topics in CNS clinical trials Develop strategies to improve the chance of success for your candidate drugs Discover how epigenetics can help in the elucidation of new targets Learn about the current targets in pain drug development and their potential for new therapies Network with key industry associates and solution providers to share valuable experiences Visit http://www.
Third Annual European Medical Device Diagnostic Sales Training Development Conference, 14-15 May 2012, Berlin, Germany
This summer, Q1 Productions will host for a third year its medical device and diagnostic sales training program specifically for executives working in European markets. Leading companies and industry experts will come together to share the latest in their understanding and challenges in developing a sales force in the medical device and diagnostic industries. As the global economy and health policy evolve, so does the healthcare industry, sales representatives and training methods. To keep sales reps most effective, trainers must always be at the forefront of industry knowledge and technology advancement. At this year's Q1 sales training program, the medical device and diagnostic industries' leading minds will discuss real hurdles they have crossed and challenges ahead, as well as key tools and solutions they use when designing and executing sales training and education platforms.
This May, Q1 Productions will host leaders and innovators from pharmaceutical and biotechnology industries in Baltimore to discuss challenges and following with management strategies to best navigate the regulatory submissions process. As industry trends move toward expedited product launches, efficient, successful regulatory submissions are crucial to moving new pharmaceutical products forward. Regulatory operations are therefore attempting more than ever before to expertly manage the large amounts of clinical data and supporting evidence required in submissions to be translated, formatted and compiled correctly. Additionally, the process is streamlined when medical writers and operations have a thorough understanding of FDA requirements and deadlines. This upcoming executive meeting will pull apart all of these regulatory submissions requirements and how to fulfill them most efficiently.
Pharmaceutical Medical Device Sales Training Development In Latin America Conference, 7-8 May 2012, Miami, FL
This summer in Miami, Q1 Productions will host an executive-level conference, bringing together seasoned professionals and pioneers in sales training from all sides of industry to discuss the opportunities presented in Latin American medical device and pharmaceutical markets to create effective and successful sales programs. With pharmaceutical and medical device markets in Latin American countries - particularly Mexico and Brazil - growing rapidly and making their way into the world's largest, it is becoming more important for trainers to craft unique curricula and programs for their sales representatives in the region. Q1's Sales Training and Development in Latin America event this summer will elucidate this relatively new market, providing tools and manageable strategies in further developing and strengthening sale straining specific to Latin America.